BSEBoard Meeting6d ago · 9 Aug 2026, 05:09 pm

Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Update on board meeting 1. ....

Natural Capsules Ltd · 524654

✦ AI SummaryFundraise

Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the unaudited consolidated & standalone financial results for the quarter ended June 30, 2026, and also to evaluate a proposal for raising funds by way of issue of equity shares, convertibles, and/or any other eligible securities on a preferential basis.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk3/10
Liquidity Impact7/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natural Capsules Ltd - 524654 - Update on board meeting

Attachments (1)

📄

431bee30-82eb-40c5-b139-6978ebaf3b36.pdf

pdf

Download →
View document text
A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY Date: August 09, 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, PJ Towers Exchange Plaza, C-1, Block G Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai – 400001 Mumbai – 400051 Scrip Code: 524654 Symbol: NATCAPSUQ Sub: In addition to intimation for Board Meeting dated August 4, 2026 – Addition to Agenda regarding Board Meeting scheduled on Wednesday August 12, 2026, Dear Sir / Madam, Further to our intimation dated August 4, 2026 informing the Exchange(s) about the Board Meeting Scheduled to be held on Wednesday August 12, 2026, inter alia, to consider and approve the Unaudited Consolidated & Standalone Financial Results for the quarter ended June 30, 2026, we wish to further inform that the Board of Directors will, at the said meeting, also consider the following additional item of business: 1. Evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential basis, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for prevention of Insider Trading and Code of Corporate Disclosure Practices, We wish to inform you that the “Trading Window” for dealing in the Equity Shares of the Company has remained closed for all Designated Person and their Immediate Relatives w.e.f. July 01, 2026 till the conclusion of 48 hours after the declaration of Financial Results of the Company for the Quarter ended June 30, 2026. Yours Faithfully, For Natural Capsules Limited Akshay Dutta Company Secretary and Compliance Officer M.No. A80481